%0 Journal Article
%T Value of the TruGraf Blood Test as a Biomarker for Monitoring Renal Transplant Recipients | Insight Medical Publishing
%A Abecassis MM
%A Clark D
%A David J
%A First MR
%A Friedewald JJ
%A Kurian S
%A Lee D
%A Lewis P
%A McNulty M
%A Pierry D
%A Rose S
%A Schieve C
%A Weiss G
%A Whisenant T
%J Journal Impact Factor:
%D 2018
%R 10.21767/2572-5610.10043
%X Kidney transplantation is the optimal treatment for many patients with end-stage kidney disease. The short-term outcomes of kidney transplantation have improved in the past few decades as a result of development of newer immunosuppressive drugs, more effective anti-microbial prophylaxis, and improved surgical techniques; however, long-term outcomes remain suboptimal. Routine posttransplant monitoring consists of the measurement of serum creatinine (SCr) and immunosuppressive drug levels. However, both are insensitive and non-specific markers of graft damage.
%U http://biomedicine.imedpub.com/value-of-the-trugraf-blood-test-as-a-biomarker-for-monitoring-renal-transplant-recipients.php?aid=22476